{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T19:02:18Z","timestamp":1782932538146,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijcard.2017.02.013","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T14:39:12Z","timestamp":1486996752000},"page":"85-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study"],"prefix":"10.1016","volume":"233","author":[{"given":"Hsiu-Chen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Daimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yow-Shieng","family":"Uang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo-Ju","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8047-5310","authenticated-orcid":false,"given":"Li-Hsuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijcard.2017.02.013_bb0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/gerona\/59.2.M161","article-title":"Prevalence and risk factors for angina in elderly Taiwanese","volume":"59","author":"Lin","year":"2004","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"5","key":"10.1016\/j.ijcard.2017.02.013_bb0010","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1001124","article-title":"Gout","volume":"364","author":"Neogi","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2017.02.013_bb0015","first-page":"301","article-title":"Trends in hyperuricemia and gout prevalence: nutrition and health survey in Taiwan from 1993\u20131996 to 2005\u20132008","volume":"20","author":"Chuang","year":"2011","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"1","key":"10.1016\/j.ijcard.2017.02.013_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.7326\/0003-4819-131-1-199907060-00003","article-title":"Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study","volume":"131","author":"Culleton","year":"1999","journal-title":"Ann. Intern. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2017.02.013_bb0025","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.numecd.2010.08.005","article-title":"Uric acid does not affect the prevalence and extent of coronary artery disease. results from a prospective study","volume":"22","author":"De Luca","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"8","key":"10.1016\/j.ijcard.2017.02.013_bb0030","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.ijcard.2017.02.013_bb0035","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar3322","article-title":"Hyperuricemia and the risk for subclinical coronary atherosclerosis-data from a prospective observational cohort study","volume":"13","author":"Krishnan","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"3","key":"10.1016\/j.ijcard.2017.02.013_bb0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijcard.2011.06.055","article-title":"Hyperuricemia and increased risk of ischemic heart disease in a large Chinese cohort","volume":"154","author":"Chuang","year":"2012","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2017.02.013_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/rheumatology\/kes169","article-title":"Risk of myocardial infarction among patients with gout: a nationwide population-based study","volume":"52","author":"Kuo","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ijcard.2017.02.013_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1124\/pr.58.1.6","article-title":"Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"12","key":"10.1016\/j.ijcard.2017.02.013_bb0055","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1124\/dmd.105.006056","article-title":"Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent benzbromarone","volume":"33","author":"Iwanaga","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/j.ijcard.2017.02.013_bb0060","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.amjcard.2004.06.032","article-title":"Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk","volume":"94","author":"Mercuro","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"9732","key":"10.1016\/j.ijcard.2017.02.013_bb0065","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(10)60391-1","article-title":"Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial","volume":"375","author":"Noman","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ijcard.2017.02.013_bb0070","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jacc.2010.12.052","article-title":"Mechanistic insights into the therapeutic use of high-dose allopurinol in angina pectoris","volume":"58","author":"Rajendra","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.ijcard.2017.02.013_bb0075","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.freeradbiomed.2005.06.004","article-title":"Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease","volume":"39","author":"Baldus","year":"2005","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2017.02.013_bb0080","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9149(76)90061-8","article-title":"A general cardiovascular risk profile: the Framingham Study","volume":"38","author":"Kannel","year":"1976","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2017.02.013_bb0085","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2017.02.013_bb0090","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2017.02.013_bb0095","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1073\/pnas.87.4.1620","article-title":"Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide","volume":"87","author":"Beckman","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.ijcard.2017.02.013_bb0100","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1021\/ic00216a003","article-title":"Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution","volume":"24","author":"Blough","year":"1985","journal-title":"Inorg. Chem."},{"issue":"5","key":"10.1016\/j.ijcard.2017.02.013_bb0105","doi-asserted-by":"crossref","first-page":"E481","DOI":"10.1152\/ajpendo.00540.2011","article-title":"Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities","volume":"302","author":"Kietadisorn","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2017.02.013_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fimmu.2013.00237","article-title":"Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase","volume":"4","author":"Kuo","year":"2013","journal-title":"Front. Immunol."},{"issue":"6708","key":"10.1016\/j.ijcard.2017.02.013_bb0115","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/24261","article-title":"Vascular biology. old-timer makes a comeback","volume":"396","author":"Vanhoutte","year":"1998","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijcard.2017.02.013_bb0120","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2004.07.003","article-title":"Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients","volume":"177","author":"Ascer","year":"2004","journal-title":"Atherosclerosis"},{"issue":"2 Pt 2","key":"10.1016\/j.ijcard.2017.02.013_bb0125","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/hy0202.103417","article-title":"Perindopril alters vascular angiotensin converting enzyme, AT1 receptor and nitric oxide synthase expression in patients with coronary heart disease","volume":"39","author":"Zhuo","year":"2002","journal-title":"Hypertension"},{"issue":"20","key":"10.1016\/j.ijcard.2017.02.013_bb0130","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa042739","article-title":"Angiotensin converting enzyme inhibition in stable coronary artery disease","volume":"351","author":"Braunwald","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijcard.2017.02.013_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.5688\/aj710595","article-title":"Antianginal actions of beta-adrenoceptor antagonists","volume":"71","author":"O'Rourke","year":"2007","journal-title":"Am. J. Pharm. Educ."},{"issue":"8","key":"10.1016\/j.ijcard.2017.02.013_bb0140","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","article-title":"Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin","volume":"100","author":"Ikonomidis","year":"1999","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317306915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317306915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T09:04:55Z","timestamp":1749978295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317306915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":28,"alternative-id":["S0167527317306915"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.013","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allopurinol, benzbromarone and risk of coronary heart disease in gout patients: A population-based study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2017.02.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}